• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

Introduction to Benzyl N-(2-chloro-3-iodopyridin-4-yl)carbamate (CAS No. 2680871-80-9)

Benzyl N-(2-chloro-3-iodopyridin-4-yl)carbamate, a compound with the chemical identifier CAS No. 2680871-80-9, has garnered significant attention in the field of pharmaceutical research due to its unique structural properties and potential applications. This compound belongs to the class of pyridine derivatives, which are widely recognized for their diverse biological activities and roles in drug development. The presence of both chloro and iodine substituents on the pyridine ring enhances its reactivity, making it a valuable scaffold for synthetic chemists and medicinal chemists alike.

The molecular structure of Benzyl N-(2-chloro-3-iodopyridin-4-yl)carbamate consists of a pyridine core substituted at the 2-position with a chloro group and at the 3-position with an iodine atom. The 4-position of the pyridine ring is linked to a carbamate group, which is further connected to a benzyl moiety. This specific arrangement of functional groups imparts distinct chemical and biological properties, making the compound a promising candidate for various therapeutic applications.

In recent years, there has been a surge in research focused on developing novel small molecules that can modulate biological pathways associated with diseases such as cancer, inflammation, and neurodegenerative disorders. Pyridine derivatives have emerged as a crucial class of compounds due to their ability to interact with biological targets at the molecular level. The 2-chloro-3-iodopyridin-4-yl moiety in Benzyl N-(2-chloro-3-iodopyridin-4-yl)carbamate is particularly noteworthy, as it has been shown to exhibit potent activity against certain enzymes and receptors involved in disease progression.

One of the most compelling aspects of this compound is its potential as an intermediate in the synthesis of more complex pharmacophores. The chloro and iodine substituents provide versatile handles for further functionalization, allowing researchers to tailor the compound's properties for specific applications. For instance, palladium-catalyzed cross-coupling reactions can be employed to introduce additional aromatic or heterocyclic moieties, thereby expanding the compound's biological profile.

Recent studies have highlighted the role of Benzyl N-(2-chloro-3-iodopyridin-4-yl)carbamate in inhibiting the activity of certain kinases and other enzymes that are overexpressed in cancer cells. The carbamate group, in particular, has been shown to interact with the active sites of these enzymes, leading to their inhibition and subsequent disruption of signaling pathways that promote tumor growth. Additionally, the presence of both chloro and iodine atoms allows for further derivatization, enabling the creation of analogs with enhanced potency and selectivity.

The benzyl moiety attached to the carbamate group not only contributes to the overall stability of the compound but also serves as a platform for additional modifications. For example, Suzuki-Miyaura coupling reactions can be utilized to introduce aryl groups at this position, thereby expanding the compound's pharmacological spectrum. Such modifications have been shown to improve solubility and bioavailability, which are critical factors in drug development.

In addition to its applications in oncology, Benzyl N-(2-chloro-3-iodopyridin-4-yl)carbamate has shown promise in other therapeutic areas. Researchers have explored its potential as an anti-inflammatory agent by investigating its ability to modulate inflammatory cytokines and mediators. The compound's ability to interact with cellular receptors and enzymes involved in inflammation suggests that it could be a valuable tool in developing novel treatments for chronic inflammatory diseases.

The synthesis of Benzyl N-(2-chloro-3-iodopyridin-4-yl)carbamate involves multiple steps, each requiring careful optimization to ensure high yield and purity. The initial step typically involves the preparation of 2-chloro-3-halo-pyridines, which are then coupled with benzoyl chloride under basic conditions to form the carbamate derivative. Further functionalization can be achieved through various chemical transformations, depending on the desired final product.

The use of modern analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography has been instrumental in characterizing the structure of Benzyl N-(2-chloro-3-iodopyridin-4-y l)carbamate and understanding its reactivity. These techniques provide detailed insights into the compound's molecular architecture, helping researchers predict its biological behavior and optimize its synthetic routes.

As research continues to advance, new applications for Benzyl N-(2-chloro -3 -iodopyridin -4 -y l)carbamate are likely to emerge. Its unique structural features and reactivity make it a versatile building block for developing novel therapeutics across multiple disease areas. By leveraging cutting-edge synthetic methodologies and exploring its pharmacological potential, scientists are poised to unlock new possibilities in drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)